CO7170177A2 - Composición de factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas - Google Patents
Composición de factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativasInfo
- Publication number
- CO7170177A2 CO7170177A2 CO15010369A CO15010369A CO7170177A2 CO 7170177 A2 CO7170177 A2 CO 7170177A2 CO 15010369 A CO15010369 A CO 15010369A CO 15010369 A CO15010369 A CO 15010369A CO 7170177 A2 CO7170177 A2 CO 7170177A2
- Authority
- CO
- Colombia
- Prior art keywords
- composition
- treatment
- growth factors
- neurodegenerative diseases
- blood plasma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención tiene como objeto el tratamiento de enfermedades neurodegenerativas u otras patologías aplicables mediante la aplicación intranasal de una composición obtenida a partir de al menos un compuesto sanguíneo con factores de crecimiento, o mediante una sustancia terapéutica obtenida a partir de dicha composición, así como la propia composición. Se garantiza que la composición alcanza el sistema nervioso central de forma eficaz desde el punto de vista del tratamiento y al mismo tiempo de forma segura para el paciente.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201200810A ES2442242B1 (es) | 2012-08-09 | 2012-08-09 | Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación. |
Publications (1)
Publication Number | Publication Date |
---|---|
CO7170177A2 true CO7170177A2 (es) | 2015-01-28 |
Family
ID=49111229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO15010369A CO7170177A2 (es) | 2012-08-09 | 2015-01-20 | Composición de factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas |
Country Status (17)
Country | Link |
---|---|
US (2) | US20140044795A1 (es) |
EP (1) | EP2883569B1 (es) |
JP (1) | JP6339568B2 (es) |
KR (1) | KR102149162B1 (es) |
CN (1) | CN104519961A (es) |
AR (1) | AR092086A1 (es) |
BR (1) | BR112015002760A2 (es) |
CA (1) | CA2881075A1 (es) |
CL (1) | CL2014003510A1 (es) |
CO (1) | CO7170177A2 (es) |
ES (2) | ES2442242B1 (es) |
IN (1) | IN2014MN02675A (es) |
MX (1) | MX357828B (es) |
PE (1) | PE20150616A1 (es) |
RU (1) | RU2696497C2 (es) |
TW (1) | TWI649084B (es) |
WO (1) | WO2014023860A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2016003282A1 (es) | 2016-12-21 | 2017-08-18 | Univ Chile | Virus aav/igf2, método de tratamiento genético y su uso en enfermedades relacionadas con mal plegamiento de proteínas tal como la enfermedad de huntington |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE310501T1 (de) * | 1998-12-09 | 2005-12-15 | Chiron Corp | Verabreichung von neurotropischen wirkstoffen in das zentrale nervensystem |
AR022333A1 (es) * | 1999-01-26 | 2002-09-04 | Anitua Aldecoa Eduardo | Regenerador de tejido oseo |
US6811777B2 (en) * | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
US7608258B2 (en) * | 2002-04-13 | 2009-10-27 | Allan Mishra | Method for treatment of tendinosis using platelet rich plasma |
ES2221770B2 (es) | 2002-04-19 | 2006-07-16 | Eduardo Anitua Aldecoa | Metodo de preparacion de un compuesto para la regeneracion de tejidos. |
US20060004189A1 (en) * | 2004-07-02 | 2006-01-05 | James Gandy | Compositions for treating wounds and processes for their preparation |
JP2009506076A (ja) * | 2005-08-26 | 2009-02-12 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ | 三叉神経疼痛のための薬物送達のための治療手順 |
JP2011504163A (ja) * | 2007-06-08 | 2011-02-03 | ヘルスパートナーズ リサーチ ファウンデーション | 中枢神経系への治療化合物の標的化を高めるための薬学的組成物および方法 |
ES2333498B1 (es) * | 2007-08-02 | 2011-01-10 | Biotechnology Institute, I Mas D, S.L. | Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. |
CN101821283A (zh) * | 2007-09-14 | 2010-09-01 | Scil技术股份有限公司 | Slit,nephrin,肝配蛋白或脑信号蛋白用于治疗软骨疾病的用途 |
MX336273B (es) | 2009-05-14 | 2016-01-13 | Biotechnology Inst I Mas D Sl | Metodo para la preparacion de al menos un compuesto a partir de sangre, y dispositivo de extraccion para ser utilizado en la ejecucion de dicho metodo. |
KR101114712B1 (ko) * | 2009-10-23 | 2012-02-29 | 세원셀론텍(주) | 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(prp)을 활성화하여 조직재생을 유도하는 조성물의 제조방법 |
ES2369945B1 (es) | 2011-07-29 | 2012-10-15 | Eduardo Anitua Aldecoa | Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento. |
-
2012
- 2012-08-09 ES ES201200810A patent/ES2442242B1/es not_active Expired - Fee Related
-
2013
- 2013-07-19 CN CN201380041280.4A patent/CN104519961A/zh active Pending
- 2013-07-19 PE PE2015000116A patent/PE20150616A1/es not_active Application Discontinuation
- 2013-07-19 KR KR1020157001551A patent/KR102149162B1/ko active IP Right Grant
- 2013-07-19 BR BR112015002760A patent/BR112015002760A2/pt not_active Application Discontinuation
- 2013-07-19 RU RU2015104076A patent/RU2696497C2/ru active
- 2013-07-19 TW TW102125858A patent/TWI649084B/zh not_active IP Right Cessation
- 2013-07-19 ES ES13756518.0T patent/ES2662385T3/es active Active
- 2013-07-19 WO PCT/ES2013/000176 patent/WO2014023860A1/es active Application Filing
- 2013-07-19 EP EP13756518.0A patent/EP2883569B1/en not_active Not-in-force
- 2013-07-19 JP JP2015525915A patent/JP6339568B2/ja not_active Expired - Fee Related
- 2013-07-19 MX MX2015001677A patent/MX357828B/es active IP Right Grant
- 2013-07-19 CA CA2881075A patent/CA2881075A1/en not_active Abandoned
- 2013-08-08 US US13/962,340 patent/US20140044795A1/en not_active Abandoned
- 2013-08-08 AR ARP130102835A patent/AR092086A1/es unknown
-
2014
- 2014-12-23 CL CL2014003510A patent/CL2014003510A1/es unknown
- 2014-12-31 IN IN2675MUN2014 patent/IN2014MN02675A/en unknown
-
2015
- 2015-01-20 CO CO15010369A patent/CO7170177A2/es unknown
-
2016
- 2016-03-08 US US15/063,969 patent/US20160184360A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CL2014003510A1 (es) | 2015-05-04 |
US20160184360A1 (en) | 2016-06-30 |
ES2442242B1 (es) | 2014-11-25 |
PE20150616A1 (es) | 2015-05-25 |
TWI649084B (zh) | 2019-02-01 |
EP2883569A1 (en) | 2015-06-17 |
KR102149162B1 (ko) | 2020-08-31 |
AR092086A1 (es) | 2015-03-25 |
RU2015104076A (ru) | 2016-09-27 |
US20140044795A1 (en) | 2014-02-13 |
RU2696497C2 (ru) | 2019-08-02 |
CA2881075A1 (en) | 2014-02-13 |
MX357828B (es) | 2018-07-25 |
JP6339568B2 (ja) | 2018-06-06 |
TW201408310A (zh) | 2014-03-01 |
WO2014023860A1 (es) | 2014-02-13 |
IN2014MN02675A (es) | 2015-08-28 |
EP2883569B1 (en) | 2017-12-20 |
JP2015524464A (ja) | 2015-08-24 |
MX2015001677A (es) | 2015-04-10 |
BR112015002760A2 (pt) | 2020-04-22 |
CN104519961A (zh) | 2015-04-15 |
KR20150040860A (ko) | 2015-04-15 |
ES2442242A1 (es) | 2014-02-10 |
ES2662385T3 (es) | 2018-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL253062B (en) | Pyrazine compounds for the treatment of infectious diseases | |
EP3180009A4 (en) | Zoledronic acid dosage forms for the treatment of pain | |
IL253945B (en) | kdm1a inhibitors to treat the disease | |
EP3212233A4 (en) | Combination therapy for treatment of disease | |
EP3148569A4 (en) | Therapeutic tratment of skin disease with recombinant commensal skin microorganisms | |
ZA201805545B (en) | Oromucosal nanofiber carriers for therapeutic treatment | |
CL2018001502A1 (es) | Procedimiento para el tratamiento de efluente acuoso. | |
IL259297A (en) | Heterocyclic compounds for the treatment of disease | |
GB201506654D0 (en) | Formulations for inhibition of PCSK9 for the treatment of hypercholesterolemia | |
IL261116A (en) | A drug for the treatment of diabetic foot infections | |
EP3259346A4 (en) | P63 inactivation for the treatment of heart failure | |
CO7170177A2 (es) | Composición de factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas | |
IL259381B (en) | Miravegron for the treatment of retinal diseases | |
PL3689341T3 (pl) | Gabapentyna okulistyczna do leczenia deepitelializacji rogówki | |
CL2015001705A1 (es) | Uso de pidotimod para tratar la psoriasis | |
GB201522994D0 (en) | The combination of chinese medicine for treating ADHD | |
GB201501800D0 (en) | Treatment of medical conditions | |
EA201692164A1 (ru) | Лекарственное средство для лечения пациентов с тиннитусом | |
LV15072A (lv) | Farmaceitiska kompozīcija izmantošanai patoloģiska stāvokļa, kam raksturīga paaugstināta iNOS gēna ekspresija, profilaksei un ārstēšanai |